Article Text

Download PDFPDF
Painful neuropathy with skin denervation after prolonged use of linezolid
  1. C-C Chao1,
  2. H-Y Sun2,
  3. Y-C Chang1,
  4. S-T Hsieh1,3
  1. 1
    Department of Neurology, National Taiwan University Hospital, Taipei 10002, Taiwan
  2. 2
    Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan
  3. 3
    Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei 10051, Taiwan
  1. Dr Sung-Tsang Hsieh, Department of Neurology, National Taiwan University Hospital, 7 Chung-Shan S. Road, Taipei 10002, Taiwan; shsieh{at}


The prolonged use of linezolid, a new antibiotic against drug-resistant Gram-positive pathogens, might cause painful neuropathy. This finding raises the possibility that small-diameter sensory nerves in the skin, which are responsible for transmitting nociceptive information, might be affected. We report a 53-year-old female who developed pure small-fibre painful neuropathy (visual analogue scale, VAS = 82 on 0–100 scale) with marked skin denervation in the leg (epidermal nerve density, END = 2.32 fibres/mm, norm <5.88 fibres/mm) and significant elevation of the warm threshold in the foot (40.0°C, norm <39.4°C) after the use of linezolid for 6 months. Eight months after the discontinuation of linezolid, the skin became fully reinnervated (END = 9.04 fibres/mm), with disappearance of neuropathic pain (VAS = 0) and normalisation of the warm threshold (36.3°C). Nerve conduction studies for large-diameter motor and sensory nerves were normal. This report documents a pure small-fibre sensory neuropathy after prolonged use of linezolid, and the relationship between skin innervation and corresponding neuropathic pain.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.